What causes Raynaud's phenomenon?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Raynaud's Phenomenon

Raynaud's phenomenon is primarily caused by vasospasm of the digital arteries, which can occur as a primary condition (primary Raynaud's) or secondary to underlying pathologies such as autoimmune disorders, particularly systemic sclerosis. 1, 2

Primary vs. Secondary Raynaud's

Primary Raynaud's (Raynaud's Disease)

Primary Raynaud's occurs without any identifiable underlying cause and involves:

  • Increased activation of sympathetic nerves in response to cold or emotional stress 3
  • Local vascular dysfunction rather than structural abnormalities 3
  • Increased sensitivity to cold of the adrenergic receptors on digital artery vascular smooth muscle 3

Secondary Raynaud's

Secondary Raynaud's is associated with:

  • Autoimmune/connective tissue diseases - particularly systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis 4, 2
  • Vascular pathologies - including atherosclerosis and thromboangiitis obliterans (Buerger's disease) 4
  • Hematological disorders - such as prothrombotic diseases with abnormalities in the clotting system 4
  • Medication use - ergot alkaloids, bleomycin, and clonidine can trigger vasospasm 1
  • Occupational factors - vibration injury (e.g., from pneumatic tools) 1

Pathophysiological Mechanisms

The pathophysiology of Raynaud's phenomenon involves several mechanisms:

  1. Vasospastic component:

    • Abnormal sympathetic nervous system activation 3
    • Impaired habituation of cardiovascular response to stress 3
  2. Vascular mediators:

    • Increased levels of vasoconstrictors (endothelin, 5-hydroxytryptamine, thromboxane) 3
    • Deficiency or increased degradation of nitric oxide 3
    • Increased oxidative stress 3
  3. In systemic sclerosis:

    • Progressive obliterative microangiopathy in addition to vasospasm 2
    • Structural vascular damage that compounds functional vasospasm 2

Common Triggers

Raynaud's attacks are commonly precipitated by:

  • Cold exposure - the most common trigger 1, 5
  • Emotional stress 1, 5
  • Smoking 1
  • Certain medications - particularly vasoconstrictive drugs 1, 5

Clinical Manifestations

Raynaud's phenomenon typically presents with:

  • Triphasic color changes - white (ischemia), blue (deoxygenation), and red (reperfusion) 3
  • Pain and/or paresthesia due to sensory nerve ischemia 3
  • Digital ischemia - potentially leading to ulceration and tissue loss in severe cases, particularly with secondary Raynaud's 2

Important Considerations

  • Recent research challenges the purely "episodic" nature of Raynaud's, particularly in systemic sclerosis, suggesting more persistent vascular compromise 2
  • The term "primary Raynaud's" may encompass several distinct entities including functional vasospastic disorder, physiological thermoregulatory responses, subclinical atherosclerosis, and "cold intolerance" 2
  • Secondary Raynaud's, particularly associated with systemic sclerosis, carries a higher risk of digital ulceration and tissue loss compared to primary Raynaud's 2

Understanding the specific cause of Raynaud's is crucial for determining appropriate management strategies and preventing complications, particularly in cases of secondary Raynaud's where the underlying condition requires targeted treatment.

References

Guideline

Raynaud's Phenomenon Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mechanisms of Raynaud's disease.

Vascular medicine (London, England), 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Managing Raynaud's phenomenon: a practical approach.

American family physician, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.